ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/08/2025
Back to search
Official data from USPTO
KARYOPHARM THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KARYOPHARM THERAPEUTICS
ST13
US500000086051670Class
5
Filing
86051670
Registration
4676225
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
03/10/2026
Trademark type
Word
Nice classes
5
Filing date
08/29/2013
Registration date
01/20/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2025
Last transaction
03/10/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/12/2014
First use in commerce
11/12/2014
Drawing code
4
Owner type
03
Owner location
Newton, MA, US
Examiner
PARK, JENNY K
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Representatives
Nicole Kinsley Foley Hoag LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsdrugs for the treatment of cancerinflammation and other diseases related to cell proliferation in humans and animals
Publications
History of USPTO decisions and trademark events.
51 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/13/2025
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/13/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2025
E15R
TEAS SECTION 15 RECEIVED
01/07/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
01/07/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/16/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/20/2024
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
07/07/2021
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/07/2021
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
07/07/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/07/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/07/2021
E15R
TEAS SECTION 15 RECEIVED
01/19/2021
ES8R
TEAS SECTION 8 RECEIVED
01/19/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/20/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/14/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/14/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/30/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/30/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
01/20/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/13/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/12/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/11/2014
IUAF
USE AMENDMENT FILED
12/03/2014
EISU
TEAS STATEMENT OF USE RECEIVED
12/03/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/02/2014
EX1G
SOU EXTENSION 1 GRANTED
10/01/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/01/2014
EXT1
SOU EXTENSION 1 FILED
09/17/2014
EEXT
SOU TEAS EXTENSION RECEIVED
09/17/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/16/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/16/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/18/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2014
PUBO
PUBLISHED FOR OPPOSITION
01/21/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/19/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
12/18/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/18/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
12/18/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/18/2013
DOCK
ASSIGNED TO EXAMINER
12/12/2013
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
09/16/2013
ALIE
ASSIGNED TO LIE
09/11/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2013
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/05/2013
NWAP
NEW APPLICATION ENTERED
09/02/2013
Continuous trademark protection
Get notified about every new filing that threatens KARYOPHARM THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.